Coronavirus tests in the United States are declining even as infections remain the main ones and the death toll rises to more than 1,000 per day, a disturbing trend that officials largely characterize the discouragement of Americans who have to wait hours for a check and days or weeks to locate the results.
An analysis through The Associated Press found that the amount of evidence consistent with the day was reduced from 3.6% in the last two weeks to 750,000, with a reduction in 22 states. This includes places like Alabama, Mississippi, Missouri and Iowa, where the % positive test age is higher and continues to increase, an indicator that the virus is still spreading unchecked.
In the midst of the crisis, some fitness officials are calling for the advent of a type of control that produces effects in minutes and is reasonable and undeniable enough for millions of Americans to control themselves, but also less precise.
Widespread testing is essential to engage the epidemic as the United States approaches a five-million-million-million mammoth that showed infections and more than 1,56,000 deaths of more than 700,000 worldwide.
Demand for testing is expected to increase this fall, when schools reopen and flu season arrives, the maximum is likely to exceed materials and cause additional delays and bottlenecks.
Part of the drop in testing in recent weeks that was expected after expired advertising labs suggested doctors focus on their patients at peak risk. But some fitness officials and government officials see the development of public frustration and declining demand.
In Iowa, state officials say they are less interested in checking, even though there is a bountiful supply. The state verification rate peaked in mid-July, but has fallen by 40% in the more than two weeks.
“We have the capacity. Iowans just want to try,” Gov. Kim Reynolds said last week.
Jessica Moore, of the Newberry, South Carolina campaign, said that after a personal lab lost its coVID-19 effects in mid-July, it had to be returned to a state-run pop-up site.
[Subscribe to our Health IQ newsletter for coronavirus updates]
Moore and her husband arrived early on a Saturday morning at the site, a networking center, where they waited two hours for their trial. Moore looked through the rearview mirror as other people went up, saw the long line of cars, then turned around and left.
“If other people have something to do on a Saturday and need to get tested, they probably won’t wait two hours in the South Carolina heat for a test, especially if they don’t have symptoms,” Moore said.
Before traveling from Florida to Delaware last month, Laura DuBose Schumacher enrolled to go on to a car check in Orlando with her husband. They had an hour window to get there.
They arrived at the beginning of the window, but after 50 minutes it looked like the wait would be one more hour. Others who crossed the line told them they would not receive its effects until at least five days later. They were making plans for the next day, so they gave up.
“Monday would have been useless, so we left the line, ” said Schumacher.
The number of infections shown in the United States exceeded 4.7 million, with new cases matching an average of about 60,000 a day, to more than 70,000 in the current part of July.
U.S. controls are mainly based on very delicate molecular controls that stumble upon the genetic code of coronavirus. Although control is considered to be the popular accuracy in terms of accuracy, experts increasingly say that the country’s overburdened lab formula is not able to keep up with the epidemic and produce effects in two or 3 days, when to isolate patients and involve the virus.
“They are doing the most productive task possible, however, the existing formula might not allow them to meet the demand,” Mara Aspinall of Arizona State University’s School of Health Solutions said.
Test delays have led harvard researchers and elsewhere to propose a new antigenic testing technique, an immediate generation already used to detect influenza, strep pharyngotic and other non-unusual infections. Instead of detecting the virus itself, these tests look for viral proteins or antigens, which are sometimes considered a less accurate measure of infection.
Several companies perform COVID-19 antigen tests in which you spit on a specially coated strip of paper and, if infected, adjust the color. Experts say the speed and widespread availability of these tests would more than offset their lower accuracy.
Although in the U.S. market. No such coronavirus control will be carried out, experts say that the generation is undeniable and that the barriers are more regulatory than technical. Harvard researchers say production can be temporarily successful in millions.
A proposal through Harvard researchers calls on the federal government to distribute saliva-based antigen controls of $1 to all Americans so that they can control themselves regularly, even on a daily basis.
Even with accuracy as low as 50%, the researchers estimate that paper striped tests would reveal five times as many CASES of COVID-19 than the existing lab approach, which the federal government says detects one in 10 infections.
But it faces resistance in Washington, where federal regulators have demanded at least 80% accuracy for new COVID-19 tests.
To date, the Food and Drug Administration has allowed two COVID-19 antigen tests to enter the market. These tests require a nasal pattern supervised by a fitness professional and can be performed on specialized machines found in hospitals, medical offices, and clinics.
In addition, due to the threat of false negatives, doctors may want to check a negative result with a genetic control when patients have imaginable symptoms of COVID-19.
On Tuesday, governors of Maryland, Virginia, Louisiana, and 3 states announced an agreement with the Rockefeller Foundation to acquire more than 3 million FDA-approved antigen tests, underscoring growing interest in technology.
When asked about the advent of less expensive paper tests, the government’s “test czar,” Admiral Brett Giroir, warned that its accuracy could drop from 20 to 30%.
“I don’t think it would do the American public any favors to have something that doesn’t happen seven out of ten times,” Giroir said last week. “I think it can just be catastrophic.”
—Associate press editors Brian Witte in Annapolis, Maryland, David Pitt in Des Moines, Iowa, and Mike Schneider in Orlando, Florida contributed to this story. Liu reported from Columbia, South Carolina, and Forster from New York.